Objectives: Eosinophilic esophagitis (EoE) is diagnosed with peak eosinophil count (PEC) of ≥15 intraepithelial eosinophils in at least one 40x field. Scant literature correlates additional histopathologic findings with clinical features and outcome in EoE. Our aim was to correlate 10 histopathologic criteria to clinical features, endoscopic findings, and treatment outcomes in 101 pediatric patients. Methods: EoE patients seen over a 10-year period were stratified into two groups: food-impaction (FI) n = 30 and non-Food impaction (Non-FI) n = 71. Symptoms, endoscopic (EGD) findings, and esophageal biopsies at diagnosis and follow-up were compared. Diagnosis and treatment of EoE were per consensus guidelines and clinical protocol. Symptoms were scored on a scale from 0 (absent) up to 3 (severe). Biopsies were evaluated for PEC, eosinophilic microabscesses, superficial layering of eosinophils, epithelial desquamation, basal zone hyperplasia, papillomatosis, spongiosis, fibrosis, eosinophilic degranulation, degree of involvement, and distribution of eosinophils. Non-parametric analysis and logistic regression model were utilized. Results: Mean age: 10.9 years (FI) and 10.4 years (Non-FI). Follow-up: 1.7 years (FI) and 1.1 years (Non-FI). Symptoms: For FI, dysphagia score improved, going from 3 to 1.25 (P < .001), and composite score going from 3.28 to 1.45 (P < .001); for Non-FI, dysphagia score improved, going from 1.21 to 0.71 (P < .001), and mean composite score, going from 2.49 to 1.48 (P < .001). EGD: Cumulative score improved, going from 1.8 to 1.7 in FI (P = .70) and from 1.6 to 1.5 in Non-FI (P = .08); PEC in FI improved, going from 60 to 27 (P = .03), and in Non-FI improved, going from 58 to 33 (P = .001). Additional histological features were similar in both groups at diagnosis; MAB, SLE, ED, and BZH showed linear correlation with improvement in PEC. Conclusion: Clinical features, endoscopic findings, and outcomes were similar in both groups. With treatment there was significant improvement in PEC in both groups. The 10 additional histological features were similar in both groups at diagnosis; MAB, SLE, ED, and BZH showed linear correlation with improvement in PEC.
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Gastric Submucosal Lipomatosis Presenting as Gastric Polyposis: The First Case Report and Morphometric Study of Additional 127 Gastric Bypass Specimens With a Proposal for Diagnostic Criteria
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Introduction: Gastric lipomatosis (GL) is an extremely rare entity where gastric submucosa is diffusely expanded by accumulation of fat, but without well-defined histological criteria. GL presenting as multiple polyps is not reported in the literature. We encountered such a case in a bariatric partial gastrectomy specimen, which prompted the current study to assess extent of fat in gastric submucosa in morbidly obese patients. Methods: H&E slides of 128 bariatric partial gastrectomy specimens including the index case were examined. The amount of submucosal fat was categorized as 0 (no fat), 1 (up to 70% fat), and 2 (> 70% fat). The maximum submucosal thickness was measured with the interval cutoff of 5 mm (radiologic upper normal thickness) and 10 mm. Results: The index case was of a 46-year-old morbidly obese man, who underwent preoperative endoscopy followed by bariatric partial gastrectomy. Multiple gastric polyps were noted endoscopically as well as grossly upon pathologic examination. Histological evaluation revealed GL with polypoid thickening of the submucosa up to 12 mm by fat. Of the 128 cases, seven (5.4%) fell in category 0, 90 (70.3%) in category 1, and 31 (24.2%) in category 3. Maximum submucosal thickness was <5 mm in 104 (81.3%) and ≥5 mm in 24 (18.8%) cases, in which three (2.3%) cases, including the index case, showed ≥10 mm of submucosal fat.
Conclusions:
We report a first case of GL presenting as gastric polyposis. Gastric submucosa is significantly thickened by fat and/or shows diffuse fat accumulation in 18.8% and 24.2% of morbidly obese patients, respectively. Based on our findings, we propose a submucosal thickness of a minimum of 10 mm and diffuse (>70%) fat accumulation as diagnostic criteria for GL. Using these criteria, the prevalence of GL in the morbidly obese population is 2.3%. A subset of these may present as polyps and gastric polyps secondary to GL may be under-recognized.
